Memorial Sloan Kettering Cancer Center (MSK) is a world leading institution for cancer treatment and research. We’re collaborating with MSK to expand access to precision cancer analysis capabilities worldwide.
Genomic Diagnostics improve equity of access to hereditary cancer genomic analysis in Australia with the SOPHiA DDM™ Hereditary Cancer Solution v1.1.
A Clinical Case Study about the value of the SOPHiA DDM™ HRD Dx Solution in clinical routine
The SOPHiA DDM™️ Platform enables the quick and confident assessment of ~1000 hereditary cancer samples per year.
The CNV detection algorithm in SOPHiA DDM™️ efficiently identified a complex duplication in MSH2.
Hospitals maximize efficiency of their laboratory workflow, fulfil updated Ontario guidelines and keep testing in-house.
The SOPHiA DDM Platform was a very useful tool for resolving this complex case.
The laboratory finds the community frequency tool very useful for making quick decisions about whether to deeply investigate a variant.
SOPHiA DDM™ enables the laboratory to process a large number of samples in a simple way to gain exhaustive insights.
SOPHiA GENETICS is Dasa’s partner of choice for data-driven medicine utilizing a multimodal data approach and SOPHiA DDM Trial Match.
SOPHiA DDM™’s unique community frequency tool helps to assess solid tumor variant frequency in the hospital’s cohort and globally.
SOPHiA DDM™ saves the reference center a massive amount of data analysis time so they can focus more on interpretation.
